Brief: Medexus Pharmaceuticals Enters into Expanded Licensing Agreement for Gliolan in Canada
March 4 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS ENTERS INTO EXPANDED LICENSING AGREEMENT FOR
GLIOLAN® IN
CANADA
* MEDEXUS PHARMACEUTICALS INC -MEDEXUS PLANS TO FILE FOR
REGISTRATION OF GLIOLAN WITH HEALTH CANADA IN 2019
* MEDEXUS PHARMACEUTICALS INC-EXPECTS TO RECEIVE FULL
REGISTRATION
OF GLIOLAN WITHIN 12 TO 18 MONTH FOLLOWING APPLICATION
Source text for Eikon: ID:nGNX5nLDMh
Further company coverage: MDP.V
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million